BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15552394)

  • 1. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis.
    Murray E; McAdam R; Burke MT
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmaceutical industry and oncology in central and eastern Europe.
    Ben-Am M; Gemperli B; Covelli A; Burke G
    Ann Oncol; 1999; 10 Suppl 6():15-7. PubMed ID: 10676548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New European clinical trial regulations are "unacceptable" to industry.
    Davidson S
    Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-marketing authorisation submission assessments in Europe.
    Morgan L
    Therapie; 2005; 60(3):205-8. PubMed ID: 16128260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globalization of clinical research by the pharmaceutical industry.
    Shah S
    Int J Health Serv; 2003; 33(1):29-36. PubMed ID: 12641261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the European clinical trials directive really improve clinical trial approval time?
    Lambers Heerspink HJ; Dobre D; Hillege HL; Grobbee DE; de Zeeuw D
    Br J Clin Pharmacol; 2008 Oct; 66(4):546-50. PubMed ID: 18662290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
    Bilbault P; Belorgey C; Zannad F; Golinelli D; Pletan Y;
    Therapie; 2010; 65(4):301-8, 291-9. PubMed ID: 20854751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European drug industry concerned over proposed clinical-trial legislation.
    Rogers A
    Lancet; 1997 Nov; 350(9091):1609. PubMed ID: 11655209
    [No Abstract]   [Full Text] [Related]  

  • 9. Research ethics committees in Europe: implementing the directive, respecting diversity.
    Hedgecoe A; Carvalho F; Lobmayer P; Raka F
    J Med Ethics; 2006 Aug; 32(8):483-6. PubMed ID: 16877630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal products in the European Union--between harmonization and divergence.
    Lojko N
    Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethics Review Boards discriminate the most severely ill--Swedish researchers are prevented to participate in an international study].
    Björck M; Berg B; Hedin U; Wingren U
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1356-7. PubMed ID: 20645608
    [No Abstract]   [Full Text] [Related]  

  • 12. Harmonization in the regulation of pharmaceutical research and human rights: the need to think globally.
    Dominguez-Urban I
    Cornell Int Law J; 1997; 30(2):245-86. PubMed ID: 12194190
    [No Abstract]   [Full Text] [Related]  

  • 13. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical research. Effects of European legislation and current developments].
    Sudhop T; Enzmann H; Klar R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):375-6. PubMed ID: 19343281
    [No Abstract]   [Full Text] [Related]  

  • 15. Diversified harmony: supranational and domestic regulation of pediatric clinical trials in the European Union.
    Pinxten W; Dierickx K; Nys H
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S183-98. PubMed ID: 21658637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The socio-political roots of pharmaceutical uncertainty in the evaluation of 'innovative' diabetes drugs in the European Union and the US.
    Davis C; Abraham J
    Soc Sci Med; 2011 May; 72(9):1574-81. PubMed ID: 21474222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical programs in the development of similar biotherapeutic products: rationale and general principles.
    Berghout A
    Biologicals; 2011 Sep; 39(5):293-6. PubMed ID: 21911300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex clinical, legal, and ethical issues of pregnant and postpartum women as subjects in clinical trials.
    Uhl K; Miller MA; Kennedy DL
    J Womens Health (Larchmt); 2004; 13(6):743-4. PubMed ID: 15333290
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical studies and the average American kid.
    Weiss R
    Washington Post; 2005 Aug; ():A5. PubMed ID: 16138447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.